| Literature DB >> 27446213 |
Walelign Dessie1, Gebru Mulugeta1, Surafael Fentaw2, Amete Mihret2, Mulu Hassen1, Engida Abebe3.
Abstract
Background. The emergence of multidrug resistant bacterial pathogens in hospitals is becoming a challenge for surgeons to treat hospital acquired infections. Objective. To determine bacterial pathogens and drug susceptibility isolated from surgical site infections at St. Paul Specialized Hospital Millennium Medical College and Yekatit 12 Referral Hospital Medical College, Addis Ababa, Ethiopia. Methods. A cross-sectional study was conducted between October 2013 and March 2014 on 107 surgical site infected patients. Wound specimens were collected using sterile cotton swab and processed as per standard operative procedures in appropriate culture media; and susceptibility testing was done using Kirby-Bauer disc diffusion technique. The data were analyzed by using SPSS version 20. Result. From a total of 107 swabs collected, 90 (84.1%) were culture positive and 104 organisms were isolated. E. coli (24 (23.1%)) was the most common organism isolated followed by multidrug resistant Acinetobacter species (23 (22.1%)). More than 58 (75%) of the Gram negative isolates showed multiple antibiotic resistance (resistance ≥ 5 drugs). Pan-antibiotic resistance was noted among 8 (34.8%) Acinetobacter species and 3 (12.5%) E. coli. This calls for abstinence from antibiotic abuse. Conclusion. Gram negative bacteria were the most important isolates accounting for 76 (73.1%). Ampicillin, amoxicillin, penicillin, cephazoline, and tetracycline showed resistance while gentamicin and ciprofloxacin were relatively effective antimicrobials.Entities:
Year: 2016 PMID: 27446213 PMCID: PMC4944047 DOI: 10.1155/2016/2418902
Source DB: PubMed Journal: Int J Microbiol
Sociodemographic and clinical characteristics of study subjects (n = 107).
| Characteristics | Frequency | Percentage |
|---|---|---|
|
| ||
| Female | 56 | 52.3 |
| Male | 51 | 47.7 |
|
| ||
| <10 | 2 | 1.9 |
| 10–20 | 18 | 16.8 |
| 21–30 | 36 | 33.6 |
| 31–40 | 23 | 21.5 |
| 41–50 | 9 | 8.4 |
| >50 | 19 | 17.8 |
|
| ||
| Urban | 49 | 45.8 |
| Rural | 58 | 54.2 |
|
| ||
| Illiterate | 29 | 27.1 |
| Primary | 49 | 45.8 |
| Secondary | 14 | 13.1 |
| College/university and above | 15 | 14 |
|
| ||
| Farmer | 33 | 30.8 |
| Employer | 17 | 15.9 |
| Student | 13 | 12.1 |
| Daily wage laborer | 14 | 13.1 |
| Housewife | 16 | 15 |
| Merchant | 6 | 5.6 |
| Jobless | 5 | 4.7 |
| Driver | 3 | 2.8 |
|
| ||
| Emergency | 66 | 61.7 |
| Elective | 41 | 38.3 |
|
| ||
| Laparotomy | 34 | 31.8 |
| Debridement | 29 | 27.1 |
| Appendectomy | 3 | 2.8 |
| Drainage | 9 | 8.4 |
| Incision | 5 | 4.7 |
| Cesarean section | 14 | 13.1 |
| Colostomy | 8 | 7.5 |
| Lithotomy | 3 | 2.8 |
| Mastectomy | 2 | 1.9 |
|
| ||
| Superficial | 45 | 42.1 |
| Deep tissue or organ/space | 62 | 57.9 |
|
| ||
| Preoperative | 22 | 20.5 |
| Postoperative | 100 | 93.4 |
| Not at all | 6 | 5.6 |
Bacterial pathogens isolated from postoperative surgical site infection.
| Bacterial isolate | Frequency | Percent |
|---|---|---|
|
|
|
|
|
| 19 | 18.3 |
| CoNS | 4 | 3.8 |
| Group B streptococci spp. | 5 | 4.8 |
|
| ||
|
|
|
|
|
| 24 | 23.1 |
|
| 23 | 22.1 |
|
| 10 | 9.6 |
|
| 3 | 2.9 |
|
| 6 | 5.8 |
|
| 6 | 5.8 |
|
| 1 | 0.9 |
|
| 1 | 0.9 |
|
| 2 | 1.9 |
|
| ||
|
|
|
|
CoNS: coagulase negative staphylococci; spp.: species.
Bacterial distribution based on SSI class.
| Bacterial isolate | Superficial SSI: number (%) | Deep tissue or organ/space SSI: number (%) | Total |
|---|---|---|---|
|
| 11 (22.4) | 8 (14.5) | 19 (18.3) |
| CoNS | 4 (8.2) | 0 (0) | 4 (3.8) |
| Group B streptococci spp. | 2 (4.1) | 3 (5.5) | 5 (4.8) |
|
| 9 (18.4) | 15 (27.3) | 24 (23.1) |
|
| 13 (26.5) | 10 (18.2) | 23 (22.1) |
|
| 3 (6.1) | 7 (12.7) | 10 (9.9) |
|
| 1 (0.2) | 2 (3.6) | 3 (2.9) |
|
| 2 (4.1) | 4 (7.3) | 6 (5.8) |
|
| 3 (6.1) | 3 (5.5) | 6 (5.8) |
|
| 0 (0) | 1 (1.8) | 1 (0.9) |
|
| 0 (0) | 1 (1.8) | 1 (0.9) |
|
| 1 (0.2) | 1 (1.8) | 2 (1.9) |
|
| |||
| Total | 49 | 55 |
|
CoNS: coagulase negative staphylococci; spp.: species.
Antibiotic susceptibility pattern of Gram positive bacterial isolates in postoperative surgical site infected patients in selected referral hospitals of Addis Ababa.
| Bacterial isolate | Pattern | Antimicrobial agents | ||||||
|---|---|---|---|---|---|---|---|---|
| CN | CIP | TE | PE | SXT | FOX | E | ||
|
| S | 16 (84.2) | 16 | 15 (78.9) | 1 (5.3) | 15 (78.9) | 17 (89.5) | 15 (78.9) |
| R | 3 (15.8) | 3 (15.8) | 4 (21.1) | 18 (94.7) | 4 (21.1) | 2 (10.5) | 4 (21.1) | |
|
| ||||||||
| CoNS | S | 1 (25) | 0 (0) | 3 (75) | 1 (25) | 1 (25) | 0 (0) | 1 (25) |
| R | 3 (75) | 4 (100) | 1 (25) | 3 (75) | 3 (75) | 4 (100) | 3 (75) | |
|
| ||||||||
| Group B streptococci spp. | S | 5 (100) | — | 5 (100) | 1 (20) | 5 (100) | 2 (40) | 4 (80) |
| R | 0 (0) | 0 (0) | 4 (80) | 0 (0) | 3 (60) | 1 (20) | ||
E = erythromycin, SXT = sulfamethoxazole-trimethoprim, FOX = cefoxitin, P = penicillin.
Antibiotic susceptibility pattern of Gram negative bacterial isolates in postoperative surgical site infected patients in selected referral hospitals of Addis Ababa.
| Bacterial isolate | Pat | Antimicrobial agents, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTX | C | CN | AMP | AMC | CRO | CAZ | KZ | CIP | CXM | TE | ||
|
| S | 4 (16.7) | 18 (75) | 11 (45.8) | 1 (4.2) | 3 (12.5) | 4 (16.7) | 4 (16.7) | 2 (8.3) | 8 (33.3) | 3 (12.5) | 4 (16.7) |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (16.7) | 0 (0) | 1 (4.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 20 (83.3) | 6 (25) | 13 (54.2) | 23 (95.8) | 17 (70.8) | 20 (83.3) | 19 (79.2) | 22 (91.7) | 16 (66.7) | 21 (87.5) | 20 (83.3) | |
|
| ||||||||||||
|
| S | 5 (21.7) | 6 (26) | 6 (26.1) | 0 (0) | 3 (13) | 5 (21.7) | 4 (17.4) | 0 (0) | 8 (34.8) | 0 (0) | 14 (60.9) |
| I | 0 (0) | 0 (0) | 4 (17.4) | 0 (0) | 1 (4.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 18 (78.3) | 17 (74) | 13 (56.5) | 23 (100) | 19 (82.6) | 18 (78.3) | 19 (82.6) | 23 (100) | 15 (65.2) | 23 (100) | 9 (39.1) | |
|
| ||||||||||||
|
| S | 1 (10) | 6 (60) | 6 (60) | 0 (0) | 0 (0) | 1 (0) | 2 (20) | 1 (10) | 8 (80) | 4 (40) | 7 (70) |
| R | 7 (70) | 4 (40) | 4 (40) | 10 (100) | 10 (100) | 9 (90) | 8 (80) | 9 (90) | 2 (20) | 6 (60) | 3 (30) | |
|
| ||||||||||||
|
| S | 0 (0) | 3 (100) | 2 (66.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (100) | 0 (0) | 2 (66.7) |
| R | 3 (100) | 0 (0) | 1 (33.3) | 3 (100) | 3 (100) | 3 (100) | 3 (100) | 3 (100) | 0 (0) | 3 (100) | 1 (33.3) | |
|
| ||||||||||||
|
| S | 0 (0) | 1 (16.7) | 5 (83.3) | 0 (0) | 0 (0) | 1 (16.7) | 4 (66.7) | 0 (0) | 4 (66.7) | 0 (0) | 3 (50) |
| I | 0 (0) | 2 (33.3) | 1 (16.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| R | 6 (100) | 3 (50) | 0 (0) | 6 (100) | 6 (100) | 5 (83.3) | 2 (33.3) | 6 (100) | 2 (33.3) | 6 (100) | 3 (50) | |
|
| ||||||||||||
|
| S | 3 (75) | 1 (25) | 4 (100) | 0 (0) | 2 (50) | 3 (75) | 4 (100) | 2 (50) | 4 (100) | 3 (75) | 0 (0) |
| R | 1 (25) | 3 (75) | 0 (0) | 4 (100) | 2 (50) | 1 (25) | 0 (0) | 2 (50) | 0 (0) | 1 (25) | 4 (100) | |
|
| ||||||||||||
|
| S | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | — | — | 0 (0) |
| R | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | |||
|
| ||||||||||||
|
| S | 1 (100) | 1 (100) | — | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | — | — | 0 (0) |
| R | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | ||||
|
| ||||||||||||
|
| S | 2 (100) | 2 (100) | 2 (100) | 0 (0) | 0 (0) | 2 (100) | 1 (50) | 0 (0) | — | — | 2 (100) |
| R | 0 (0) | 0 (0) | 0 (0) | 2 (100) | 2 (100) | 0 (0) | 1 (50) | 2 (100) | 0 (0) | |||
S = sensitive, I = intermediate, R = resistant, TE = tetracycline, CIP = ciprofloxacin, AMP = ampicillin, AMC = amoxicillin/clavulanic acid, CTX = cefotaxime, CAZ = ceftazidime, KZ = cephazoline, CXM = cefuroxime sodium, C = chloramphenicol, CN = gentamicin, CRO = ceftriaxone.
Multidrug resistance pattern of bacterial isolates.
| Bacterial isolate | Total number (%) | Number (%) of antimicrobial patterns | |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ≥ | ||
|
| 76 (73.1) | 1 (1.3) | 1 (1.3) | 3 (3.9) | 6 (7.6) | 7 (9.2) | 58 (76.3) |
|
| 24 (23.1) | 1 (4.2) | 0 (0) | 0 (0) | 1 (4.2) | 2 (8.3) | 20 (83.3) |
|
| 23 (22.1) | 0 (0) | 0 (0) | 0 (0) | 1 (4.3) | 0 (0) | 22 (95.7) |
|
| 10 (9.6) | 0 (0) | 0 (0) | 2 (20) | 1 (10) | 1 (10) | 6 (60) |
|
| 3 (2.9) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (100) |
|
| 6 (5.8) | 0 (0) | 0 (0) | 0 (0) | 1 (16.7) | 1 (16.7) | 4 (66.7) |
|
| 6 (5.8) | 0 (0) | 0 (0) | 1 (16.7) | 2 (33.3) | 1 (16.7) | 2 (33.3) |
|
| 1 (0.9) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
|
| 1 (0.9) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) |
|
| 2 (1.9) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 1 (50) |
|
| 28 (26.9) | 2 (7.1) | 14 (50) | 7 (25) | 1 (3.6) | 0 (0) | 4 (14.3) |
|
| 19 (18.3) | 1 (5.3) | 12 (63.2) | 5 (26.3) | 0 (0) | 0 (0) | 1 (5.3) |
| CoNS | 4 (3.8) | 0 (0) | 0 (0) | 1 (25) | 1 (25) | 0 (0) | 2 (50) |
| Group B streptococci spp. | 5 (4.8) | 1 (20) | 2 (40) | 1 (20) | 1 (20) | 0 (0) | 0 (0) |
R 0: no resistance, R 1: resistance to one drug, R 2: resistance to two drugs, R 3: resistance to three drugs, R 4: resistance to four drugs, ≥R 5: resistance to five or more drugs.